Breaking into the animal health vaccines market requires overcoming high regulatory barriers and providing speed in response to outbreaks and evolving variants. Hanjo Hennemann shares how VEROVACCiNES leveraged a recombinant platform to rapidly design, test, and scale vaccines utilising regulatory pathways for broader and faster market entry.

Hanjo Hennemann

Candise Goodwin
Candise Goodwin is a recognized leader in the pet industry, with over 15 years of experience helping companies navigate market complexity, scale solutions, and deliver measurable impact. Her background spans pivotal roles at industry leaders including Merck Animal Health, Vets First Choice, VIP Petcare/PETIQ, and Petco, where she led major digital transformations and launched numerous high-profile, industry-changing growth initiatives.
Candise has dedicated her career to understanding the challenges and opportunities within the pet industry. She has worked closely with retailers, veterinary groups, pet technology companies, product and service providers, and pharmacies - developing a holistic, customer-centric viewpoint of the industry's unique ecosystem along the way.
Today, Candise extends her expertise to clients seeking to navigate the complexities of the market. Her firm, Outlier Advisors, provides strategic consulting services that reflect her distinctive blend of innovative thinking, deep industry knowledge, and ability to spot emerging trends. Outlier Advisors partners with industry leaders, investors, and startups to develop actionable strategies that meet the demands of an evolving pet landscape.
Candise is also a sought-after speaker, advisor, author, and mentor, known for sharing rare and multifaceted insights and practical strategies with fellow Outliers.
Approval alone doesn’t guarantee commercial success. Robert Jordan shares how Vetirus Pharmaceuticals combines in-house regulatory expertise with early manufacturing planning, ensuring supply, shortening timelines to revenue, and enabling global expansion.
